Study Details
A Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASP4345 in Patients with Schizophrenia
Clinicaltrials.gov ID
Astellas Study ID
4345-CL-0002
EudraCT ID
N/A
Condition
Schizophrenia
Phase
Phase 1
Age
18 years - 60 years
Sex
Female & Male
Product
N/A
Type
Interventional
Trial Dates
Mar 2016 - Jun 2017
Masking
Double (Participant, Investigator)
Enrollment number
48
A Phase 1 Multiple Ascending Oral Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASP4345 in Patients with Schizophrenia
Study summary
Study documents
Get More Information
Would you like more information about clinical trial sites that are recruiting participants for A Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASP4345 in Patients with Schizophrenia? Contact us by filling our your information to the right and we’ll respond to you.
Locations
Site US10001
Glendale, United States, 91206